| Primary |
| Acute Myeloid Leukaemia |
15.4% |
| Multiple Myeloma |
15.4% |
| Myelodysplastic Syndrome |
9.6% |
| Myeloid Leukaemia |
7.7% |
| Non-hodgkin's Lymphoma |
7.7% |
| Acute Lymphocytic Leukaemia |
3.8% |
| Amyloidosis |
3.8% |
| Aplastic Anaemia |
3.8% |
| Chronic Myeloid Leukaemia |
3.8% |
| Hodgkin's Disease |
3.8% |
| Leukaemia Plasmacytic |
3.8% |
| Neoplasm Malignant |
3.8% |
| Transplant |
3.8% |
| Blood Stem Cell Harvest |
1.9% |
| Bone Marrow Disorder |
1.9% |
| Diffuse Large B-cell Lymphoma Recurrent |
1.9% |
| Engraft Failure |
1.9% |
| Mantle Cell Lymphoma |
1.9% |
| Refractory Anaemia With An Excess Of Blasts |
1.9% |
| Transplant Failure |
1.9% |
|
| Vomiting |
13.5% |
| Pyrexia |
10.8% |
| Engraft Failure |
8.1% |
| Pharmaceutical Product Complaint |
8.1% |
| Device Breakage |
5.4% |
| Infusion Related Reaction |
5.4% |
| Nausea |
5.4% |
| Therapeutic Product Contamination |
5.4% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
5.4% |
| Wheezing |
5.4% |
| Anaphylactoid Reaction |
2.7% |
| Bk Virus Infection |
2.7% |
| Blood Triglycerides Increased |
2.7% |
| Chest Pain |
2.7% |
| Culture Positive |
2.7% |
| Graft Versus Host Disease In Liver |
2.7% |
| Human Herpesvirus 6 Infection |
2.7% |
| Incorrect Product Storage |
2.7% |
| Infection |
2.7% |
| Loss Of Consciousness |
2.7% |
|
| Secondary |
| Prophylaxis |
21.6% |
| Acute Myeloid Leukaemia |
19.0% |
| Non-hodgkin's Lymphoma |
11.7% |
| Lymphoma |
7.8% |
| Acute Lymphocytic Leukaemia |
7.4% |
| Primitive Neuroectodermal Tumour |
7.4% |
| Aplastic Anaemia |
4.3% |
| Testicular Germ Cell Cancer |
3.5% |
| Refractory Anaemia With An Excess Of Blasts |
2.6% |
| Myelodysplastic Syndrome |
2.2% |
| Malignant Neoplasm Progression |
1.7% |
| Myeloid Leukaemia |
1.7% |
| Testicular Neoplasm |
1.7% |
| Acute Promyelocytic Leukaemia |
1.3% |
| Ovarian Epithelial Cancer |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Chronic Myeloid Leukaemia |
0.9% |
| Hodgkin's Disease |
0.9% |
| Leukaemia Plasmacytic |
0.9% |
| Mantle Cell Lymphoma |
0.9% |
|
| Vomiting |
17.5% |
| Pyrexia |
7.5% |
| Spinal Cord Disorder |
7.5% |
| Stem Cell Transplant |
7.5% |
| Lymphoma |
5.0% |
| Miller Fisher Syndrome |
5.0% |
| Pneumonia |
5.0% |
| Skin Exfoliation |
5.0% |
| Staphylococcal Sepsis |
5.0% |
| Thrombocytopenia |
5.0% |
| Thrombotic Thrombocytopenic Purpura |
5.0% |
| Venoocclusive Disease |
5.0% |
| Anaphylactoid Reaction |
2.5% |
| Cardiomyopathy |
2.5% |
| Complications Of Transplant Surgery |
2.5% |
| Dementia |
2.5% |
| Diffuse Large B-cell Lymphoma Recurrent |
2.5% |
| Encephalopathy |
2.5% |
| Febrile Neutropenia |
2.5% |
| Graft Versus Host Disease |
2.5% |
|
| Concomitant |
| Multiple Myeloma |
44.7% |
| Drug Use For Unknown Indication |
21.3% |
| Acute Myeloid Leukaemia |
5.1% |
| Lymphoma |
3.4% |
| Primitive Neuroectodermal Tumour |
2.8% |
| Stem Cell Transplant |
2.8% |
| Transplant |
2.8% |
| Immunosuppression |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Acute Promyelocytic Leukaemia |
1.7% |
| Acute Lymphocytic Leukaemia |
1.4% |
| B-cell Lymphoma |
1.4% |
| Diffuse Large B-cell Lymphoma Stage Ii |
1.4% |
| Chronic Myeloid Leukaemia |
1.1% |
| Hypertension |
1.1% |
| Nausea |
1.1% |
| Prophylaxis |
1.1% |
| Prophylaxis Against Graft Versus Host Disease |
1.1% |
| Bone Marrow Transplant |
0.6% |
| Chronic Sinusitis |
0.6% |
|
| Osteonecrosis |
12.5% |
| Wound Decomposition |
10.7% |
| Renal Failure Acute |
7.1% |
| Thrombocytopenia |
7.1% |
| Tooth Extraction |
7.1% |
| Wound Debridement |
7.1% |
| Stem Cell Transplant |
5.4% |
| Herpes Zoster |
3.6% |
| Pancytopenia |
3.6% |
| Peritoneal Tuberculosis |
3.6% |
| Pneumonia |
3.6% |
| Pneumonia Bacterial |
3.6% |
| Renal Tubular Atrophy |
3.6% |
| Salivary Gland Cancer |
3.6% |
| Sepsis |
3.6% |
| Toothache |
3.6% |
| Vomiting |
3.6% |
| Wound Treatment |
3.6% |
| Abdominal Pain |
1.8% |
| Cataract |
1.8% |
|
